DC
AURA icon

Decheng Capital’s Aura Biosciences AURA Stock Holding History

Decheng Capital’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-360,483
Closed -$1.96M – 15
2025
Q4 		$1.96M Sell
360,483
-155,072
-30% -$921K 0.26% 14
2025
Q3 		$3.19M Hold
515,555
– – 0.56% 15
2025
Q2 		$3.23M Hold
515,555
– – 0.82% 15
2025
Q1 		$3.02M Hold
515,555
– – 0.85% 19
2024
Q4 		$4.24M Hold
515,555
– – 0.91% 21
2024
Q3 		$4.59M Hold
515,555
– – 1.09% 15
2024
Q2 		$3.9M Hold
515,555
– – 1.19% 16
2024
Q1 		$4.05M Hold
515,555
– – 0.54% 17
2023
Q4 		$4.57M Buy
+515,555
New +$4.37M 1.28% 16

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return